To see the effect of Haridradwaya Churna with and without Vamana Karma in trating Sthaulya (Dyslipidemia).

To evaluate the efficacy of Haridradwaya Churna with and without Vamana Karma in the management of Sthaulya w.s.r. to Dyslipidemia- A randomised comparative clinical study.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/023742

Enrollment

Registered

2020-03-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Haridradwaya choorna with Vamana Karma: Haridradwaya churna 6 grams orally twice a day before food for 30 days. VAMANA- Vatsaka beeja churna-3gms Madana phala pippali churna-3g

Eligibility

Inclusion criteria

Inclusion criteria: Age group : Between 25 -60 years serum cholesterol (201 mg/dl or more) serum TGLs (161 mg/dl or more) Screening using inclusion and exclusion criteria Diagnosis Randomisation using CRT On 31 th day FOLLOW UP serum HDL (below 40 mg/dl) serum LDL (131 mg/dl or more) serum VLDL (41 mg/dl or more) will be included in the study.

Exclusion criteria

Exclusion criteria: 1.Systemic illness which will interfere with the course of procedure. 2.Patients unfit for Vamana karma

Design outcomes

Primary

Measure	Time frame
Reduction in the levels of 1. Serum Cholesterol 2. Serum Triglycerides 3. Serum HDL 4. Serum LDL 5. Serum VLDL Timepoint: 1st and 30th day	—

Secondary

Measure	Time frame
1. Improvement in dehabala, agnibala and chetasbala 2. Random Blood Sugar level 3. BMI 4. Waist to hip ratio 5. Reduction in body weight 6. Assessment of Dosha, Dhatu,And MalaTimepoint: 1st day and 30th day	—

Countries

India

Contacts

Public ContactDr S K Bhatted

All India Institute of Ayurveda

dracharyadr@hotmail.com9879550157

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026